JB/CALL/MERCK & CO./130/0.05/21.06.24 | Real-time Bid/Ask 14:15:27 22/05/2024 BST | ||
| 0.12 CHF / 0.13 CHF | -16.67% |
|
| 1 month | -6.25% | ||
| 3 months | -28.57% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 16/05/24 | 0.15 | +7.14% |
| 15/05/24 | 0.14 | +27.27% |
Delayed Quote Swiss Exchange
Last update May 16, 2024 at 04:20 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Bank Julius Bär |
| MRKCJB | |
| ISIN | CH1242071129 |
| Date issued | 06/01/2023 |
| Strike | 130 $ |
| Maturity | 21/06/2024 (30 Days) |
| Parity | 20 : 1 |
| Emission price | 0.45 CHF |
| Emission volume | N/A |
| Settlement | cash |
| Currency | CHF |
Technical Indicators
| Highest since issue | 0.42 CHF |
|---|---|
| Lowest since issue | 0.022 CHF |
| Spread | 0.01 CHF |
| Spread % | 7.69% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.8
USD
Average target price
141.6
USD
Spread / Average Target
+8.32%
- Stock Market
- Warrants
- MRKCJB Warrant
